TuHURA pro forma 2025 net loss $34.6M after Kineta acquisition; exec bonuses approved

TuHURA Biosciences, Inc./NV

Pro forma net loss attributable to common stockholders $34.57M, or $(0.64) per share, for year ended Dec 31, 2025.
Kineta merger closed June 30, 2025; Kineta shareholders received ~3.998M TuHURA shares (7.6% post-merger ownership).
Concurrent June 2025 private placement raised $11.5M net from 4.76M shares and warrants at $2.65/unit.
CEO Bianco awarded $490,536 bonus; new salary $605,956. CFO Dearborn awarded $163,393 bonus; new salary $403,676.
No cash consideration paid at closing due to Kineta working capital deficit of $5.255M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.